Valuation: Lactose (India) Limited

Market Cap 1.01B 10.52M 9.16M 8.46M 7.76M 14.76M 15.01M 101M 39.53M 495M 39.49M 38.63M 1.7B P/E 2024
25.9x
P/E 2025 21.8x
Enterprise Value 1.54B 15.96M 13.9M 12.84M 11.78M 22.39M 22.77M 153M 59.98M 751M 59.91M 58.6M 2.58B EV / Sales 2024
1.87x
EV / Sales 2025 1.41x
Free-Float
41.28%
Yield 2024 *
-
Yield 2025 -
1 day+3.35%
1 week+0.29%
Current month-0.53%
1 month-5.44%
3 months+12.69%
6 months+0.39%
Current year+0.73%
1 week 95
Extreme 95
105.95
1 month 95
Extreme 95
110.8
Current year 76.01
Extreme 76.01
136.45
1 year 76.01
Extreme 76.01
136.7
3 years 45
Extreme 45
247.4
5 years 31.45
Extreme 31.45
247.4
10 years 14.35
Extreme 14.35
247.4
Manager TitleAgeSince
Chief Executive Officer 61 -
Director of Finance/CFO 59 2016-05-27
Chief Operating Officer - -
Director TitleAgeSince
Chairman 61 -
Director/Board Member 59 2014-01-23
Director/Board Member 65 2024-08-07
Change 5-day change 1-year change 3-year change Capi.($)
+3.35%+0.29%+2.89%+128.10% 13.11M
-0.02%-1.48%+8.49%-20.29% 267B
-0.14%-2.49%-13.19%-18.76% 75.48B
+0.20%-2.89%+5.34%+29.17% 52.54B
+0.02%+5.24%+51.57%+5.24% 39.66B
-0.69%-3.23%+3.25%-28.72% 34.78B
-0.88%-3.86%+44.04%+105.27% 33.34B
+1.48%+0.59%-8.45%-29.01% 29.74B
+0.01%-3.15%+19.12%+23.29% 28.62B
-0.78%+4.34%+54.31%+16.10% 22.63B
Average +0.26%-0.78%+16.74%+21.04% 58.39B
Weighted average by Cap. -0.05%-1.14%+11.48%-4.13%

Financials

2024 2025
Net sales 1.14B 11.83M 10.31M 9.52M 8.74M 16.6M 16.89M 113M 44.48M 557M 44.43M 43.46M 1.92B 1.16B 12.09M 10.54M 9.73M 8.93M 16.97M 17.26M 116M 45.46M 569M 45.41M 44.42M 1.96B
Net income 67.89M 705K 614K 567K 521K 990K 1.01M 6.76M 2.65M 33.18M 2.65M 2.59M 114M 51.63M 536K 467K 432K 396K 753K 766K 5.14M 2.02M 25.23M 2.01M 1.97M 86.88M
Net Debt 377M 3.92M 3.41M 3.15M 2.89M 5.5M 5.59M 37.57M 14.73M 184M 14.72M 14.39M 635M 523M 5.44M 4.74M 4.38M 4.02M 7.63M 7.76M 52.14M 20.44M 256M 20.42M 19.97M 881M
Logo Lactose (India) Limited
Lactose (India) Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. The Company specializes in the manufacturing of excipients (lactose/liquid color coatings), lactulose, solid dosage forms and liquid dosage forms. It specializes in manufacturing of lactose monohydrate IP/BP/EP/USP-NF grades. The Company’s lactose products include Formulac 200M, Formulac 80M, Formulac 100M, Formulac 325M, Formulac DC60, Formulac 450M, Formulac 314M and Formulac DC2050. It is also engaged in the manufacturing of disaccharide lactulose, a versatile bulk API. Disaccharide Lactulose (galacto-fructose) is synthesized from lactose (galacto-glucose) by isomerization of glucose to fructose. Lactulose is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, chronic liver disease and as an effective prebiotic.
Employees
140
Date Price Change Volume
26-07-15 ₹103.35 +3.35% 10,525
26-07-14 ₹100.00 -0.15% 919
26-07-13 ₹100.15 +0.15% 1,520
26-07-10 ₹100.00 +1.21% 4,077
26-07-09 ₹98.80 -3.33% 18,909
  1. Stock Market
  2. Stocks
  3. LACTOSE6 Stock